Home > National Drug Code (NDC) > Carisoprodol and Aspirin

Carisoprodol and Aspirin - 23155-145-01 - (Carisoprodol and Aspirin)

Alphabetical Index


Drug Information of Carisoprodol and Aspirin

Product NDC: 23155-145
Proprietary Name: Carisoprodol and Aspirin
Non Proprietary Name: Carisoprodol and Aspirin
Active Ingredient(s): 325; 200    mg/1; mg/1 & nbsp;   Carisoprodol and Aspirin
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carisoprodol and Aspirin

Product NDC: 23155-145
Labeler Name: Heritage Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA089594
Marketing Category: ANDA
Start Marketing Date: 20110331

Package Information of Carisoprodol and Aspirin

Package NDC: 23155-145-01
Package Description: 100 TABLET in 1 BOTTLE (23155-145-01)

NDC Information of Carisoprodol and Aspirin

NDC Code 23155-145-01
Proprietary Name Carisoprodol and Aspirin
Package Description 100 TABLET in 1 BOTTLE (23155-145-01)
Product NDC 23155-145
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carisoprodol and Aspirin
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20110331
Marketing Category Name ANDA
Labeler Name Heritage Pharmaceuticals Inc.
Substance Name ASPIRIN; CARISOPRODOL
Strength Number 325; 200
Strength Unit mg/1; mg/1
Pharmaceutical Classes Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]

Complete Information of Carisoprodol and Aspirin


General Information